Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

primary pulmonary diffuse large B-cell lymphoma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study highlights the 'bird's nest sign' as a novel initial presentation of primary pulmonary B-cell non-Hodgkin lymphoma with plasmacytic differentiation. This finding may enhance diagnostic accuracy for this rare lymphoma subtype.

AbbVie and Genmab's dual-acting drug, Epkinly, shows promising results in a frontline trial for newly diagnosed diffuse large B-cell lymphoma (DLBCL). Analysts suggest it could become the new standard of care for this patient population.

A recent study analyzes prognostic factors and survival rates in HHV8 positive diffuse large B cell lymphoma using national cancer database data. The findings may inform treatment strategies and patient management for this rare lymphoma subtype.

A recent study highlights a rare presentation of diffuse large B-cell lymphoma, where peritoneal lymphomatosis can mimic complicated hydatid cysts on imaging. This finding emphasizes the need for careful differential diagnosis in similar cases.

Research identifies the MYD88L265P mutation as a highly specific marker for the non-GCB/ABC subtype of diffuse large B-cell lymphoma (DLBCL). This discovery could enhance diagnostic accuracy and treatment strategies for patients with this molecular subtype.

A recent case study highlights primary diffuse large B-cell lymphoma occurring in the heart, contributing to the understanding of this rare presentation. This discovery may inform future research and clinical approaches to similar cases.

ADC Therapeutics faces significant setbacks as its lymphoma drug Zynlonta, when combined with rituximab, resulted in 27 patient deaths and showed no overall survival benefit in diffuse large B cell lymphoma. This raises concerns about its viability as a second-line treatment.

A recent study published in PubMed explores the rare occurrence of extranodal male genital involvement in diffuse large B-cell lymphoma. This research adds to the understanding of the disease's atypical presentations.

A recent study highlights the diagnostic challenges posed by benign thyroid nodules that can mimic residual disease in patients with concurrent thyroid and gastric diffuse large B-cell lymphoma. The research emphasizes the importance of ultrasound-guided biopsy for accurate diagnosis.

A recent study highlights primary pulmonary MALT lymphoma as a rare condition often misdiagnosed due to its pneumonic presentation. This research underscores the need for increased awareness and accurate diagnosis of this rare lymphoma subtype.

A new study explores the link between breast implants and Epstein-Barr virus-positive diffuse large B-cell lymphoma. This research highlights potential risks associated with breast implants, contributing to the understanding of this rare lymphoma subtype.

Not rare diseases news,news about your rare disease.